STOCKHOLDERS' EQUITY (Tables)

9 Months Ended

Sep. 30, 2023

STOCKHOLDERS' EQUITY

Schedule of common stock issued roll forward

​	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Common stock:
Balance, beginning of quarter	177,900,083	163,286,569	171,656,030	155,516,284
Shares issued for stock options exercised	610,132	681,139	802,939	2,044,193
Agent growth incentive stock compensation	387,999	1,184,446	1,774,438	2,098,770
Agent equity stock compensation	1,985,169	3,410,310	6,649,976	8,903,217
Balance, end of quarter	180,883,383	168,562,464	180,883,383	168,562,464

Changes in the Company's stock compensation liability

	Amount
Balance, December 31, 2022	$ 3,885
Stock grant liability increase year to date	2,796
Stock grants reclassified from liability to equity year to date	(1,094)
Balance, September 30, 2023	$ 5,587

Schedule of shares repurchased

	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Treasury stock:
Balance, beginning of quarter	24,311,897	11,487,691	18,816,791	6,751,692
Repurchases of common stock	2,761,943	4,716,026	8,257,049	9,452,025
Forfeiture to treasury stock for acquisition	10,728	-	10,728	-
Issuance of treasury stock for acquisition	-	(343,331)	-	(343,331)
Balance, end of quarter	27,084,568	15,860,386	27,084,568	15,860,386